251 related articles for article (PubMed ID: 16503123)
21. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
Shibata N; Yamamoto T; Hiroi A; Omi Y; Kato Y; Kobayashi M
Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
[TBL] [Abstract][Full Text] [Related]
22. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
23. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
Oh YK; Shin KS; Yuan J; Kang SJ
J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
[TBL] [Abstract][Full Text] [Related]
24. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?
Kabashi E; Valdmanis PN; Dion P; Rouleau GA
Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357
[TBL] [Abstract][Full Text] [Related]
25. Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation.
Katz JS; Katzberg HD; Woolley SC; Marklund SL; Andersen PM
Amyotroph Lateral Scler; 2012 Oct; 13(6):567-9. PubMed ID: 22670877
[TBL] [Abstract][Full Text] [Related]
26. Novel SOD1 mutation p.V31A identified with a slowly progressive form of amyotrophic lateral sclerosis.
Dangoumau A; Verschueren A; Hammouche E; Papon MA; Blasco H; Cherpi-Antar C; Pouget J; Corcia P; Andres CR; Vourc'h P
Neurobiol Aging; 2014 Jan; 35(1):266.e1-4. PubMed ID: 23954173
[TBL] [Abstract][Full Text] [Related]
27. Sensorimotor and cognitive functions in a SOD1(G37R) transgenic mouse model of amyotrophic lateral sclerosis.
Filali M; Lalonde R; Rivest S
Behav Brain Res; 2011 Nov; 225(1):215-21. PubMed ID: 21816178
[TBL] [Abstract][Full Text] [Related]
28. Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis.
Garcia ML; Singleton AB; Hernandez D; Ward CM; Evey C; Sapp PA; Hardy J; Brown RH; Cleveland DW
Neurobiol Dis; 2006 Jan; 21(1):102-9. PubMed ID: 16084104
[TBL] [Abstract][Full Text] [Related]
29. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
Nakano R
Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
[TBL] [Abstract][Full Text] [Related]
30. Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice.
Staats KA; Van Helleputte L; Jones AR; Bento-Abreu A; Van Hoecke A; Shatunov A; Simpson CL; Lemmens R; Jaspers T; Fukami K; Nakamura Y; Brown RH; Van Damme P; Liston A; Robberecht W; Al-Chalabi A; Van Den Bosch L
Neurobiol Dis; 2013 Dec; 60():11-7. PubMed ID: 23969236
[TBL] [Abstract][Full Text] [Related]
31. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896
[TBL] [Abstract][Full Text] [Related]
32. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.
Rothstein JD
Ann Neurol; 2009 Jan; 65 Suppl 1():S3-9. PubMed ID: 19191304
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis and SOD1 mutation screening in Iranian amyotrophic lateral sclerosis patients.
Alavi A; Nafissi S; Rohani M; Zamani B; Sedighi B; Shamshiri H; Fan JB; Ronaghi M; Elahi E
Neurobiol Aging; 2013 May; 34(5):1516.e1-8. PubMed ID: 23062701
[TBL] [Abstract][Full Text] [Related]
34. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis.
Laferriere F; Polymenidou M
Swiss Med Wkly; 2015; 145():w14054. PubMed ID: 25635517
[TBL] [Abstract][Full Text] [Related]
35. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
36. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
37. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
Aoki M
Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
[TBL] [Abstract][Full Text] [Related]
38. Kennedy's disease: a triplet repeat disorder or a motor neuron disease?
Gallo JM
Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):209-14. PubMed ID: 11719252
[TBL] [Abstract][Full Text] [Related]
39. Genetics of amyotrophic lateral sclerosis.
Corcia P; Couratier P; Blasco H; Andres CR; Beltran S; Meininger V; Vourc'h P
Rev Neurol (Paris); 2017 May; 173(5):254-262. PubMed ID: 28449881
[TBL] [Abstract][Full Text] [Related]
40. RNA interference and amyotrophic lateral sclerosis.
Rizvanov AA; Gulluoglu S; Yalvaç ME; Palotás A; Islamov RR
Curr Drug Metab; 2011 Sep; 12(7):679-83. PubMed ID: 21740381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
